News
Two Life Sciences students have been recognised in this year’s Global Undergraduate Awards (UA). Nicole Coutinho Garrido was named as Regional Winner (Europe) while Dana Cheung was Highly Commended.
News
Two Life Sciences students have been recognised in this year’s Global Undergraduate Awards (UA). Nicole Coutinho Garrido was named as Regional Winner (Europe) while Dana Cheung was Highly Commended.
Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Press release
The University of Dundee and Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents, will partner to commercialise technology developed at Dundee that enhances the understanding of undruggable diseases.
Press release
Two sisters will make the University of Dundee’s Graduation celebrations a family affair this week.
Press release
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
Feature
Pawat Piyakitcharoen was one of the first students to study one of the new Life Sciences taught postgraduate courses. He explains how mixing science with business provided him with valuable knowledge and skills.
News
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.
News
School of Life Science’s Professor Alessio Ciulli was amongst a selected group of world’s leading expert scientists and key opinion leaders who spoke at the Galien Forum on October 24, 2019, at the Alexandria Center in New York City.
Press release
An entrepreneurial scientist from the University of Dundee has proven his business concept is more than skin deep after winning one of the country’s top enterprise awards
Press release
The University of Dundee Drug Discovery Unit is delighted to announce it has licensed assets to Corbin Therapeutics to develop possible new treatments for neuroinflammation-based disorders, including multiple sclerosis (MS).
Press release
Exscientia, a world leader in artificial intelligence (“AI”) driven drug discovery and a spinout company of the University of Dundee announced today that it has entered a three-year AI drug discovery partnership with leading biopharma company Celgene